CompletedNCT05961527
Group MDMA-therapy for Veterans With PTSD
Medication studyAges 18–64United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 64 years.
- Listed locations
- Vancouver, United StatesSee all locations and recruitment
- Activities
- Medication described in the protocol · Behavioural activities described in the protocol
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateStarted: October 1, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 23
- Sponsor
- Portland VA Research Foundation, Inc
- Sponsor type
- Non-profit organization
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 1, Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT05961527
- Official title
Show the full official title
An Open-Label Feasibility and Safety Study of MDMA-Assisted Group Therapy for the Treatment of Posttraumatic Stress Disorder in Veterans
Recruitment & locations
CompletedVancouver
Questions about this study
Who is behind this study?
The study sponsor is Portland VA Research Foundation, Inc.
Did this study involve medication?
Yes. The study involved medication, including MDMA.
Who was this study for?
Listed age limits: 18 years to 64 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me